Business Description
Tandem Diabetes Care Inc
NAICS : 339112
SIC : 3841
ISIN : US8753722037
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.98 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.97 | |||||
Debt-to-EBITDA | -4.27 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.21 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.1 | |||||
3-Year EBITDA Growth Rate | -138.3 | |||||
3-Year EPS without NRI Growth Rate | -103.1 | |||||
3-Year FCF Growth Rate | -117.4 | |||||
3-Year Book Growth Rate | -6.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.6 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.81 | |||||
Quick Ratio | 3.01 | |||||
Cash Ratio | 2.42 | |||||
Days Inventory | 137.28 | |||||
Days Sales Outstanding | 46.35 | |||||
Days Payable | 47.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 0.59 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.28 | |||||
Operating Margin % | -19.1 | |||||
Net Margin % | -18.37 | |||||
FCF Margin % | -8.67 | |||||
ROE % | -45.97 | |||||
ROA % | -14.94 | |||||
ROIC % | -39.05 | |||||
ROC (Joel Greenblatt) % | -49.02 | |||||
ROCE % | -16.8 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4 | |||||
PB Ratio | 12.56 | |||||
Price-to-Tangible-Book | 12.55 | |||||
EV-to-EBIT | -23.79 | |||||
EV-to-Forward-EBIT | 99.11 | |||||
EV-to-EBITDA | -27.28 | |||||
EV-to-Forward-EBITDA | 69.75 | |||||
EV-to-Revenue | 3.96 | |||||
EV-to-Forward-Revenue | 2.32 | |||||
EV-to-FCF | -45.94 | |||||
Price-to-Projected-FCF | 15.36 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Net-Current-Asset-Value | 81.53 | |||||
Earnings Yield (Greenblatt) % | -4.2 | |||||
FCF Yield % | -2.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tandem Diabetes Care Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 13,187.944 | ||
EPS (TTM) (MXN) | -37.117 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0 | ||
20-Day SMA (MXN) | 807.19 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 807.19 - 807.19 | ||
Shares Outstanding (Mil) | 64.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tandem Diabetes Care Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tandem Diabetes Care Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Tandem Diabetes Care Inc Frequently Asked Questions
What is Tandem Diabetes Care Inc(MEX:TNDM)'s stock price today?
When is next earnings date of Tandem Diabetes Care Inc(MEX:TNDM)?
Does Tandem Diabetes Care Inc(MEX:TNDM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |